JP Nadda urges life sciences industry to prioritize patient-centric innovation

Union Health Minister Jagat Prakash Nadda has called on India’s life sciences industry to prioritize patient-centric innovation. Speaking at the inaugural Bharat Life Sciences Award (BLSA), Nadda emphasized that true success in the sector involves moving discoveries from the laboratory to the bedside to ensure high-quality care is affordable and accessible to all citizens.

The awards, organized by the Federation of Indian Chambers of Commerce and Industry (FICCI) and supported by Eli Lilly and Company, featured Rs 7 crore in grant support and received over 500 applications. Nadda highlighted India’s leadership in vaccine manufacturing and its bioeconomy, noting that initiatives like Ayushman Bharat PM-JAY demonstrate the impact of aligning scientific capability with public purpose.

Key award recipients include Dr. Vamsee Mallajosyula of the National Centre for Biological Sciences, Pacify Medical Technologies, Bharat Serums and Vaccines, and the BRIC-National Institute of Biomedical Genomics.